Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
2013 · BMC Infectious Diseases · 32 citations
https://doi.org/10.1186/1471-2334-13-75